This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Instanyl

Takeda Pharmaceutical Company Ltd

Drug Names(s): Intranasal fentanyl spray

Description: Instanyl is an an intranasally applied fentanyl spray. Fentanyl citrate is a phenylpiperidine derivative medicinal product acting on the opioid receptor.

Deal Structure: In May 2011, Takeda Pharmaceutical and Nycomed A/S jointly announced that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the company for 9.6 billion Euro on a cash-free, debt-free basis. The purchase would exclude Nycomed's U.S. dermatology business. The acquisition closed in September 2011.


Instanyl News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug